Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 16: 185-190, 1970;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fang, V. S.
Right arrow Articles by Selenkow, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fang, V. S.
Right arrow Articles by Selenkow, H. A.

Clinical Chemistry, Vol 16, 185-190, Copyright © 1970 by the American Association for Clinical Chemistry

Determination of Free Thyroxine in Serum by Low-Temperature Equilibrium Dialysis

Victor S. Fang 1 and Herbert A. Selenkow 1

1 Departments of Medicine and Pharmacology, Harvard Medical School, Harvard School of Dental Medicine, and the Peter Bent Brigham Hospital, Boston, Mass. 02115.

Equilibrium dialysis of thyroxine (T4) in diluted serum at low temperature gives consistent and reproducible values for the dialyzable fraction (DF) of this hormone. The quantity of serum required for the determination is minimized by dilution, which is technically advantageous. Variations caused by temperature, dialysis time, dilution of serum, buffer system, and stability of 125I-T4 could be controlled by parallel use of a normal reference serum in each experiment. The reference serum was assigned a DF value of 0.04%, which was corrected by a factor derived from the ratio of assigned DF to the observed DF calculated from the experimental data for this reference serum. This correction factor permits the observed DF results for concurrent unknown samples to be related to the values for the DF of the normal reference serum. The free thyroxine concentration is calculated from the product of the DF and the total serum thyroxine concentration as determined by competitive binding analysis. The method is convenient for use in clinical laboratories, and data for free thyroxine obtained from patients with metabolic thyroid disorders are diagnostically discriminatory.

Accepted on January 2, 1970






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1970 by the American Association for Clinical Chemistry.